MedWorm: Profits and Losses

Affymetrix stock down 10% after hours on Q4 earnings

bizjournals.com Health Care:Pharmaceuticals headlines — Wed, 08 Feb 2012 22:45:30 +0100

Affymetrix Inc.'s stock was down nearly 10 percent after hours on Wednesday. It closed at $5.21 per share. The Santa Clara-based company (NASDAQ:AFFX) on Wednesday reported its fourth quarter earnings. Affymetrix makes products and services related to genetic analysis for the life science research and clinical health care markets. It reported a net loss of about $14.7 million, or 21 cents per diluted share, in the fourth quarter of 2011 compared to net income of $4 million, or 6 cents per diluted share, in the same period of 2010... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Sponsor Message: Find the best January Sales in the UK.

CVS Earnings Rise 3.7%

WSJ.com: Health — Wed, 08 Feb 2012 17:12:12 +0100

CVS Caremark's fourth-quarter profit rose 3.7% as pharmacy-services and retail revenue grew. (Source: WSJ.com: Health)

HealthOne parent HCA posts $1.9B Q4 profit

bizjournals.com Health Care:Physician Practices headlines — Wed, 08 Feb 2012 11:31:06 +0100

HCA Holdings Inc. -- parent of the Denver area's HealthOne hospitals -- saw earnings jump to $1.9 billion in the fourth quarter, thanks largely to a pretax gain of $1.5 billion stemming from its October purchase of the Colorado Health Foundation’s interest in the HealthOne system. Nashville-based HCA (NYSE: HCA) posted earnings of $4.25 per share on revenue of $7.8 billion. Excluding one-time items, earnings were 94 cents per share. Analysts, on average, had anticipated earnings of 76 cents per share on revenue of 8... (Source: bizjournals.com Health Care:Physician Practices headlines)

Amylin Takes 4Q Loss As Lilly Partnership Ends

Drugs.com - Pharma News — Tue, 07 Feb 2012 13:11:20 +0100

From Associated Press (February 7, 2012) SAN DIEGO -- Diabetes drug maker Amylin Pharmaceuticals Inc. reported a larger fourth-quarter loss Monday after it ended a partnership with Eli Lilly & Co., which gave Amylin all the... (Source: Drugs.com - Pharma News)

Lincare income drops despite revenue gain

bizjournals.com Health Care:Biotechnology headlines — Mon, 06 Feb 2012 21:58:50 +0100

Lincare Holdings Inc. reported net income for 2011 of $177.3 million, or $1.93 a share, compared to net income of $181.6 million, or $1.87 a share, in 2010. Although profit dropped, earnings per share increased in 2011 because Lincare had about 10.2 million fewer shares outstanding as of Dec. 31. Revenue for 2011 was $1.85 billion, a 10.7 percent increase over revenue of $1.7 billion in 2010, a statement from the company said. For the fourth quarter of 2011, Lincare reported net income of $44... (Source: bizjournals.com Health Care:Biotechnology headlines)

Drug maker Alkermes Fiscal 3Q Loss Widens

Drugs.com - Pharma News — Fri, 03 Feb 2012 12:09:22 +0100

From Associated Press (February 2, 2012) Drug maker Alkermes PLC’s fiscal third-quarter loss widened as operating expenses ballooned compared to the previous year’s quarter, before the company had completed its acquisition of Elan... (Source: Drugs.com - Pharma News)

Gilead Sciences 4Q Profit Rises on HIV Drug Sales

Drugs.com - Pharma News — Fri, 03 Feb 2012 12:08:50 +0100

From Associated Press (February 2, 2012) FOSTER CITY, Calif. -- Gilead Sciences Inc.'s profit grew 6 percent in the fourth quarter on greater sales of its HIV drugs including Atripla. Gilead said Thursday that its profit rose to $665.1 million, or... (Source: Drugs.com - Pharma News)

Vertex Posts 4Q Profit on Growing Incivek Sales

Drugs.com - Pharma News — Fri, 03 Feb 2012 12:08:43 +0100

From Associated Press (February 2, 2012) CAMBRIDGE, Mass. -- Drugmaker Vertex Pharmaceuticals Inc. said Thursday it turned a profit in the fourth quarter on sales of its hepatitis C pill Incivek, which was approved in May. Vertex reported a profit... (Source: Drugs.com - Pharma News)

Anger management interventions for adults with learning disabilities living in the community: a review of recent (2000–2010) evidence

British Journal of Learning Disabilities — Fri, 03 Feb 2012 05:00:00 +0100

This study looks at research on helping adults with learning disabilities to manage their anger.• More research needs to be carried out to find better ways of helping adults with learning disabilities to manage their anger.SummaryEstimates suggest that around a quarter of adults with learning disabilities living in the community have difficulties controlling their anger. Angry or aggressive behaviour can have serious repercussions, including loss of residential or day placements, admission to hospital and reduced quality of life. In addition, the psychological well being of both paid and family carers can be adversely affected. A previous review of this area (Whitaker 2001) suggested equivocal results for cognitive‐behavioural (CBT) approaches. The current study provides an update to...

Gilead Q4 profit up, but EPS miss analyst estimates

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 02 Feb 2012 21:40:30 +0100

Gilead Sciences Inc.'s stock rose 0.16 percent to close at $49.31 per share on Thursday, but was trading more than 1 percent down after hours. The Foster City-based biopharmaceutical company (NASDAQ:GILD) reported net income for the fourth quarter of 2011 of $665.1 million, or 87 cents per diluted share, compared to $629.4 million, or 76 cents per diluted share for the fourth quarter of 2010. The company said fourth quarter revenue increased 10 percent to $2.20 billion, from $2 billion for the fourth quarter of 2010... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Pfizer, Lilly Profits Fall as Drugs Lose Patents

WSJ.com: Health — Wed, 01 Feb 2012 03:26:32 +0100

Pfizer and Lilly were hurt by the "patent cliff," with each reporting declines in fourth-quarter profit due to new generic competition for top-selling drugs. (Source: WSJ.com: Health)

Self‐management strategies in overweight and obese Canadians with arthritis

Arthritis Care and Research — Fri, 27 Jan 2012 10:29:33 +0100

ConclusionFewer than half of the overweight and obese Canadians with arthritis engaged in both weight control/loss and exercise. The provision of targeted clinical recommendations (particularly low in individuals that did not engage in any self‐management strategies) may help to facilitate participation. (Source: Arthritis Care and Research)

Hill-Rom's 1Q sales improve, but profit dips

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 26 Jan 2012 19:44:25 +0100

Hill-Rom Holdings Inc. (NYSE: HRC) reported first-quarter revenue of $381 million, up 2 percent from the same period a year ago. Net income decreased to $33 million from $35 million. Earnings per share fell 4 percent to 53 cents from 55 cents. The results were in line with what the Batesville, Ind.-based company had predicted, as reported by Business First earlier this month. Analysts had, on average, predicted revenue of just under $385 million and earnings of 53 cents a share. Gains in the hospital bed maker’s North American acute-care business were offset by declines in other areas, especially Latin America and Europe... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Novartis net profit falls 47%

Pharmaceutical Technology — Thu, 26 Jan 2012 00:00:00 +0100

Novartis has reported that its fourth quarter net profit fell 47% to $1.21bn as the company felt the impact of a previously disclosed charge of $900m, relating to a forecasted decline for sales of its Tekturna drug. (Source: Pharmaceutical Technology)

Novartis's Profit Drops

WSJ.com: Health — Wed, 25 Jan 2012 19:19:22 +0100

Novartis issued a cautious earnings outlook for 2012 as it reported a 46% drop in fourth-quarter net profit, hit by restructuring costs, R&D write-offs, continued drug price cuts and the strong Swiss franc. (Source: WSJ.com: Health)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

WellPoint Profit Drops 39% as Costs Rise

WSJ.com: Health — Wed, 25 Jan 2012 15:50:34 +0100

WellPoint's fourth-quarter earnings fell 39% as investment losses and higher costs hurt the health insurer. (Source: WSJ.com: Health)

Novartis Profit Drops 46%

WSJ.com: Health — Wed, 25 Jan 2012 09:00:58 +0100

J&J Net Slumps on Charges

WSJ.com: Health — Wed, 25 Jan 2012 02:52:13 +0100

Johnson & Johnson reported an 89% drop in fourth-quarter profit due to legal settlements and product-liability costs, but the health-care giant avoided a third consecutive year of sales declines in 2011. (Source: WSJ.com: Health)

GE Healthcare reports uptick in revenues for Q4, FY2011

CMIO.net: The News Weekly for Health IT Executives — Mon, 23 Jan 2012 09:27:32 +0100

GE Healthcare has reported a 1 percent increase in fourth quarter revenues to $5.16 billion, and a slight drop—5 percent—in quarter profits to $953 million. However, the yearly revenue in 2011 rose 7 percent in 2011 over 2010—$18.08 billion versus $16.9 billion. Likewise, the healthcare unit’s yearly profits rose 2 percent from $2.74 billion in 2010 to $2.8 billion in 2011. (Source: CMIO.net: The News Weekly for Health IT Executives)

Southwest Airlines Reports Fourth Quarter Results And 39th Consecutive Year Of Profitability

Pharmaceutical Online News — Thu, 19 Jan 2012 05:31:00 +0100

Southwest Airlines Co.(the "Company") recently reported its fourth quarter and full year 2011 results. Fourth quarter 2011 net income was $152M, or $.20 per diluted share, which included $86M (net) of favorable special items. (Source: Pharmaceutical Online News)

Psychiatric Issues in Cosmetic Plastic Surgery

Psychiatric Quarterly — Wed, 18 Jan 2012 06:59:45 +0100

The objective of cosmetic surgery is increased patient self-esteem and confidence. Most patients undergoing a procedure report these results post-operatively. The success of any procedure is measured in patient satisfaction. In order to optimize patient satisfaction, literature suggests careful pre-operative patient preparation including a discussion of the risks, benefits, limitations and expected results for each procedure undertaken. As a general rule, the patients that are motivated to surgery by a desire to align their outward appearance to their body-image tend to be the most satisfied. There are some psychiatric conditions that can prevent a patient from being satisfied without regard aesthetic success. The most common examples are minimal defect/Body Dysmorphic Disorder, the ...

Conserving Biodiversity Could Benefit the World's Poor

BioScience Press Releases — Sun, 15 Jan 2012 08:32:21 +0100

Land areas that are a priority for wildlife conservation provide relatively high levels of ecosystem services such as pollination, water purification, food production, and climate regulation, so safeguarding them is expected to benefit people. Assessing these benefits to populations in ways that are useful to decisionmakers who guide conservation efforts has, however, proved difficult. A global analysis published in the January 2012 issue of BioScience by Will R. Turner of Conservation International and his colleagues breaks new ground by analyzing the flow of benefits from ecosystem services under a variety of socioeconomic assumptions and in greater spatial detail than previous studies. The analysis, which divides the globe into more than 58,000 hexagons, finds that over half the global...

Outlook for Indian pharma cos remain stable: CARE

The Economic Times Healthcare and Biotech News — Wed, 11 Jan 2012 11:13:54 +0100

Indian Pharma companies credit profile remains stable but forex losses and high interest rate cost might impact this quarter, says Care Ratings. (Source: The Economic Times Healthcare and Biotech News)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Philips warns on fourth-quarter profits

FT.com - Drugs and Healthcare — Tue, 10 Jan 2012 11:25:28 +0100

The Dutch electronics manufacturer warned that the worsening economy in Europe would drag down fourth quarter profits (Source: FT.com - Drugs and Healthcare)

Jazz closes up more than 9% on outlook

bizjournals.com Health Care:Biotechnology headlines — Fri, 06 Jan 2012 21:42:46 +0100

Jazz Pharmaceuticals Inc.'s stock closed Friday at $45.39 per share, up 9.49 percent. The jump comes following the Palo Alto-based specialty pharmaceutical company (NASDAQ:JAZZ) saying Thursday it is expecting a larger profit in 2012, following its purchase of Azur Pharma Ltd. The deal witth Azur is expected to close the week of Jan. 16. It also said sales of its narcolepsy drug, Xyrem, have done well. "We were pleased with the strong performance of Xyrem in 2011, including 9 percent year-over-year volume growth in the fourth quarter and 11 percent volume growth for the full year, as we continue to invest in this important product," said Bruce Cozadd, the chairman and CEO of Jazz Pharmaceuticals in a prepared statement... (Source: bizjournals.com Health Care:Biotechnology headlines)

Happy pill prescriptions soar to 50m as job and money fears grow

the Mail online | Health — Fri, 30 Dec 2011 12:53:39 +0100

Experts claim the rise has been partly triggered by job losses and financial woes caused by the economic crisis. Around a quarter of Britons are thought to suffer from some form of mental illness every year. (Source: the Mail online | Health)

Antidepressant use in England soars

Guardian Unlimited Science — Fri, 30 Dec 2011 00:06:20 +0100

• Prescriptions rise by more than a quarter in three years • Depression costing economy nearly £11bn a year• Financial uncertainty thought to be factorThe use of antidepressants has risen by more than a quarter in England in just three years, amid fears that more people are suffering from depression due to the economic crisis.The number of prescriptions for antidepressants increased by 28% from 34m in 2007-08 to 43.4m in 2010-11, according to the NHS information centre.Depression is also costing the economy nearly £11bn a year in lost earnings, NHS care and drug prescriptions.Research by the House of Commons found the cost to the NHS of treating the illness is more than £520m a year.People who are unable to work due to depression lose £8.97bn of potential earnings a year, while t...

MedWorm Sponsor Message: Find the best January Sales in the UK.

A quarter causing intermittent gastric outlet obstruction

Gastrointestinal Endoscopy — Wed, 28 Dec 2011 12:50:19 +0100

A 45-year-old man presented with 8 weeks of episodic postprandial nausea, vomiting, and abdominal distention lasting 2 to 3 hours and occurring every 3 to 4 days. The episodes resolved with no specific treatment but continued to occur every 3 to 4 days. Between episodes, the patient felt fine and had no abdominal pain, weight loss, altered bowel habits, or change in appetite. Abdominal examination showed normal results. Complete blood count, urinalysis, liver biochemical tests, serum amylase, and lipase results were all normal. A CT scan showed a 2.4-cm metal disk in the gastric antrum (), and an upper endoscopy was ordered to follow-up the abnormal CT result. EGD confirmed a heavily corroded quarter (), which was retrieved by using a Roth net. After the quarter was scrubbed, we could see ...

Centene among Fortune 500's top performers

bizjournals.com Health Care:Physician Practices headlines — Wed, 21 Dec 2011 21:45:21 +0100

Centene Corp. was the only St. Louis-based company to make CNN Money’s Top 10 list of Fortune 500 companies for 2011, based on stock closing prices Dec. 9. The company continued its winning ways by hitting a new 52-week high this week. Centene (NYSE: CNC), which ranks No. 493 on the Fortune 500, ranked No. 10 on this year’s performers’ list. Shares of Centene have risen 48 percent year-to-date and closed today at $39.85, up from $26.07 a year ago. The company, led by Chairman and CEO Michael Neidorff, posted a profit of $29 million in the third quarter, up 28 percent from a year earlier, due to an increased number of members and expansion into Florida, Illinois, Mississippi and Texas... (Source: bizjournals.com Health Care:Physician Practices headlines)

BASi Reports Fiscal 2011 Net Income Of $543,000 Versus A Loss of $2.7M In Fiscal 2010 As Revenue Increased 15.2% To $33.1M

Pharmaceutical Online News — Tue, 20 Dec 2011 06:59:00 +0100

Bioanalytical Systems, Inc. (BASi) recently announced financial results for the fourth quarter and fiscal year ended September 30, 2011. (Source: Pharmaceutical Online News)

Patheon reports higher revenue, net loss

bizjournals.com Health Care:Biotechnology headlines — Mon, 19 Dec 2011 22:35:50 +0100

Patheon, a contract manufacturer headquartered in Durham, on Monday reported higher revenue but also higher net losses for the fiscal year ended in October. This year, Patheon (TSX: PTI) recorded a net loss of $16.8 million, more than triple the net loss of $5 million in 2010. For the year, the company reported $700 million in revenue, up 4 percent from 2010. Patheon posted a fourth quarter net loss of $5.4 million, compared to a $1.8 million loss in the 2010 fourth quarter. Patheon is a contract manufacturer for the pharmaceutical industry... (Source: bizjournals.com Health Care:Biotechnology headlines)

[Review] Anaemia in low-income and middle-income countries

LANCET — Fri, 16 Dec 2011 12:02:44 +0100

SummaryAnaemia affects a quarter of the global population, including 293 million (47%) children younger than 5 years and 468 million (30%) non-pregnant women. In addition to anaemia's adverse health consequences, the economic effect of anaemia on human capital results in the loss of billions of dollars annually. In this paper, we review the epidemiology, clinical assessment, pathophysiology, and consequences of anaemia in low-income and middle-income countries. Our analysis shows that anaemia is disproportionately concentrated in low socioeconomic groups, and that maternal anaemia is strongly associated with child anaemia. (Source: LANCET)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Polydex Pharmaceuticals Ltd. Reports Continued Quarterly Profitability

Medical News (via PRIMEZONE) — Thu, 15 Dec 2011 14:00:00 +0100

TORONTO, Dec. 15, 2011 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink/OTCBB:POLXF) reports financial results for its third fiscal quarter, the three-month period ended October 31, 2011, demonstrating three consistent quarters of profitability. (Source: Medical News (via PRIMEZONE))

Intrapartum care at a tertiary hospital in Cambodia: A survey using the Bologna Score.

Midwifery — Tue, 13 Dec 2011 05:00:00 +0100

CONCLUSION: the Bologna Score was easy to use and pointed at items that could be improved. It was satisfying that all women survived, but alarming that 16% of the children had a low Apgar score. The findings suggest that childbirth care can be improved at the hospital. PMID: 22172744 [PubMed - as supplied by publisher] (Source: Midwifery)

Synergetics profit jumps 22% in Q1

bizjournals.com Health Care:Physician Practices headlines — Mon, 12 Dec 2011 22:20:31 +0100

Synergetics reported today a profit of $771,000 in the first quarter, up 22 percent from $633,000 in the prior-year quarter. The O’Fallon, Mo.-based medical device maker (NASDAQ: SURG) reported record sales of $13.5 million for the quarter ended Oct. 31, up 12 percent from $12.1 million a year earlier. The sales results were in line with what the company had predicted for first-quarter revenue last month. The growth in first quarter sales was the result of higher sales of domestic ophthalmology products, Synergetics said... (Source: bizjournals.com Health Care:Physician Practices headlines)

2010 spike in Greenland ice loss lifted bedrock, GPS reveals

ScienceDaily Headlines — Fri, 09 Dec 2011 17:32:32 +0100

An unusually hot melting season in 2010 accelerated ice loss in southern Greenland by 100 billion tons – and large portions of the island's bedrock rose an additional quarter of an inch in response. That's the finding from a network of nearly 50 GPS stations planted along the Greenland coast to measure the bedrock's natural response to the ever-diminishing weight of ice above it. (Source: ScienceDaily Headlines)

Randomised trials on secondary prevention of low back pain in occupational settings

Occupational and Environmental Medicine — Thu, 08 Dec 2011 05:00:00 +0100

In most industrialised countries, the institutions managing the healthcare system are increasingly concerned by rising trends in disability and work loss due to low back pain (LBP). From a public health perspective, a health problem such as LBP, that affects 30%–45% of the adult population annually, would certainly demand primary prevention programs. Although such programs have proven helpful for other prevalent conditions such as cardiovascular diseases, they have not yet been shown to be effective for LBP in spite of a quarter of a century of effort and scientific trials.1 2 While these negative results are not a compelling reason to abandon well-designed multidimensional prevention programs, they do provide public health authorities and medical professionals with a strong incentiv...

MedWorm Sponsor Message: Find the best January Sales in the UK.

Few Parents Recall Being Told By Doctors That Their Child Is Overweight

Health News from Medical News Today — Tue, 06 Dec 2011 09:00:00 +0100

A new analysis of national survey data finds that less than one-quarter of parents of overweight children recall ever being told by a doctor or other health care provider that their children were overweight. And although that percentage has increased over the last 10 years, more improvement is needed, said Eliana M. Perrin, MD, MPH, associate professor in the University of North Carolina at Chapel Hill School of Medicine, pediatrician at North Carolina Children's Hospital, and lead author of the study... (Source: Health News from Medical News Today)

Dollar General Tackles 'Food Deserts'

RWJF News Digest - Childhood Obesity — Tue, 06 Dec 2011 05:00:00 +0100

As Dollar General posted yet another strong quarterly profit on Monday, the discount retailer said it soon will turn its attention to targeting food deserts — areas not served by supermarkets or nearby grocers — in a bid to fill voids in many communities. (Source: RWJF News Digest - Childhood Obesity)

Children With HIV/AIDS Falling Through The Cracks Of Treatment Scale-Up Efforts

Health News from Medical News Today — Sat, 03 Dec 2011 08:00:00 +0100

Less than one-quarter (23%) of children with HIV/AIDS who need treatment are getting it, according to a report released by the World Health Organization (WHO) on the occasion of World AIDS Day (1 December 2011). Although treatment coverage for adults has been steadily climbing and has now reached approximately half of those in need, coverage for children is lagging far behind, highlighted the Drugs for Neglected Diseases initiative (DNDi), a non-profit research and development organization that has recently launched a new paediatric HIV drug development programme... (Source: Health News from Medical News Today)

Children with HIV/AIDS falling through the cracks of treatment scale-up efforts

EurekAlert! - Medicine and Health — Thu, 01 Dec 2011 05:00:00 +0100

(Drugs for Neglected Diseases Initiative) Less than one-quarter (23 percent) of children with HIV/AIDS who need treatment are getting it, according to a report released by the WHO on the occasion of World AIDS Day. Although treatment coverage for adults has been steadily climbing and has now reached approximately half of those in need, coverage for children is lagging far behind, highlighted DNDi, a non-profit research and development organization that has recently launched a new pediatric HIV drug development program. (Source: EurekAlert! - Medicine and Health)

Effect of colleague and coworker abuse on family physicians in Canada.

Canadian Family Physician Medecin de Famille Canadien — Thu, 01 Dec 2011 05:00:00 +0100

Conclusion Although only a small number of family physicians experience abuse by physician colleagues and other coworkers, the effects can be considerable. Victims reported a loss of confidence in their clinical abilities and some subsequently were faced with mental health issues. PMID: 22170201 [PubMed - in process] (Source: Canadian Family Physician Medecin de Famille Canadien)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Books of the year 2011

Guardian Unlimited Science — Fri, 25 Nov 2011 18:27:56 +0100

A novel about a dinner-party guest who won't leave, a history of Henry VII, an inquiry into madness … Which books have most impressed our writers this year?• Join the debate and let us know which were your books of 2011 Chimamanda AdichieI admired the lovely sentences and moving story in Sebastian Barry's On Canaan's Side (Faber), about an Irish-American woman looking back at her life. Binyavanga Wainaina's One Day I Will Write About This Place (Granta) is a strange, allusive, tender memoir about growing up in middle-class Kenya. Tracy K Smith's poems in Life on Mars (Turnaround) are startling and exquisite.Tariq AliShifting alliances at home and abroad, ruthless accumulation of capital and endless court intrigues form the backdrop to Thomas Penn's Winter King: The Dawn of Tudor E...

Recognizing the symptoms of meningitis

Thrive, Children's Hospital Boston — Wed, 23 Nov 2011 15:36:27 +0100

A Boston middle school student died earlier this week, and bacterial meningitis is thought to be the cause of death. According to reports, the young girl complained to a school nurse that she felt sick on Friday; by Monday night she had died. Meningitis is the term for an infection that affects the brain and spinal cord. There are lots of different kinds, from mild types of viral meningitis that completely resolve without any problems, to the severe kind of bacterial meningitis that is being blamed for this young girl’s death. It’s a tragic story and one that’s likely to get media coverage because of the patient’s young age and the fact that bacterial meningitis can be contagious. It’s most likely to be transmitted from person to person in close living quarters, especially throug...

Amphibians facing 'terrifying' rate of extinction

Guardian Unlimited Science — Wed, 16 Nov 2011 18:56:00 +0100

Researchers say tropical regions of richest diversity are most at risk of losing frogs, toads, newts and salamandersIf the current rapid extermination of animals, plants and other species really is the "sixth mass extinction", then it is the amphibian branch of the tree of life that is undergoing the most drastic pruning.In research described as "terrifying" by an independent expert, scientists predict the future for frogs, toads, newts and salamanders is even more bleak than conservationists had realised.Around half of amphibian species are in decline, while a third are already threatened with extinction. But scientists now predict that areas with the highest diversity of amphibian species will be under the most intense threat in the future.And they warn that a three-pronged threat could ...

Teeth-whitening firms filing suit against state, dentists

L.A. Times - Health — Tue, 15 Nov 2011 23:57:00 +0100

Small businesses say dentists don't want them taking bite out of profitsThe Council for Cosmetic Teeth Whitening estimates that teeth whitening is now an $11 billion-per-year industry. The suit contends that small, teeth-whitening businesses typically charge customers as little as a quarter of what is charged by licensed dental offices. (Source: L.A. Times - Health)

NuPathe Plans New Zelrix Filing in Early 2012

Drugs.com - Pharma News — Tue, 15 Nov 2011 16:47:57 +0100

From Associated Press (November 14, 2011) CONSHOHOCKEN, Pa. -- NuPathe Inc. reported a smaller third-quarter loss Monday, and said it will file a new marketing application for its migraine patch Zelrix in the first half of 2012. Shares of the... (Source: Drugs.com - Pharma News)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Health professional advice for smoking and weight in adults with and without diabetes: findings from BRFSS

Journal of Behavioral Medicine — Tue, 15 Nov 2011 06:47:11 +0100

Abstract Health risk behaviors including smoking and weight-gain can cause and exacerbate chronic diseases like diabetes. Brief provider advice is an effective intervention to reduce risk from these behaviors. However, behavioral advice is provided more often to those who already have a chronic illness when compared with those who are at risk. The purpose of this study is to determine whether the frequency of provider advice for smoking cessation and weight loss varies between overweight or obese smokers with and without diabetes. BRFSS data from a subset of overweight and obese smokers with (n = 848) and without (n = 6,279) diabetes were analyzed to determine differences in reported provider advice. Overweight and obese smokers with diabetes reported re...

Heavy drinking in pregnancy can alter unborn babies' brains, study shows

Guardian Unlimited Science — Sun, 13 Nov 2011 19:54:20 +0100

People born to alcoholic mothers at risk of problems ranging from poor brain development to loss of hearing and visionHeavy drinking during pregnancy could alter the genetic makeup of unborn babies' brains, causing mental and behavioural problems.People born to alcoholic mothers are at risk of problems ranging from poor brain development and faulty nervous systems to a loss of hearing and vision that persists throughout their lives.Although the medical conditions caused by heavy drinking in pregnancy are well documented, scientists have been less sure about how alcohol causes such irreversible damage to the developing brain.To investigate, a team led by Jerold Chun, a neuroscientist at the Scripps Research Institute in California, studied how alcohol affected the brains of mice as the anim...

Alimera Implosion Analysis, What Is Next (ALIM, PSDV)

BioHealth Investor — Fri, 11 Nov 2011 21:17:03 +0100

Alimera Sciences, Inc. (NASDAQ: ALIM) is the latest of the drug implosions and this one looks even worse than just severely damaging. The FDA’s complete response letter is really a request for additional data. This is almost as bad as it could be, short of an outright rejection with an order of termination, for its diabetic macular edema (vision-loss for diabetics) drug candidate called ILUVIEN. The reason the stock was down so much (almost 75%) is because we can’t see how the company can adequately fund the next trial and the next trial after that. One trial, maybe. Two, no way. The company had less than $39 million in cash on hand as of the end of September and its quarterly loss was $6.5 million in the last quarter even though its R&D expenses were lower. Th...

ThermoGenesis reports drop in sales, revenue

bizjournals.com Health Care:Biotechnology headlines — Thu, 10 Nov 2011 22:25:40 +0100

ThermoGenesis Corp. reported a drop in sales for the quarter ended Sept. 30 due to the global debt crisis and increased competition in U.S. and European cord blood markets. Revenue for the first quarter of the company’s new fiscal year were $4.9 million, down from $7 million for the same quarter last year. Disposable sales were $3.5 million compared to $4.4 million. The Rancho Cordova-based company reported a net loss of $1.2 million for the quarter. This compares to a net loss of $68,000 for the same period last year... (Source: bizjournals.com Health Care:Biotechnology headlines)

Tranzyme sees net loss jump

bizjournals.com Health Care:Biotechnology headlines — Thu, 10 Nov 2011 22:06:20 +0100

Drug developer Tranzyme Inc. on Thursday announced that it had posted a net loss of $6.4 million in the 2011 third quarter. That was up from a net loss of $1.5 million in the 2010 third quarter. The surge in the net loss was largely attributable to an increase in research and development expenses. R&D expenses were $7 million in the third quarter of 2011 as compared to $2.4 million for the same period in 2010. The increase during the period reflects costs associated with the two Phase 3 pivotal trials for ulimorelin and the Phase 2b clinical trial for TZP-102, the company said... (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Cubist’s merger partner Adolor swings to third-quarter profit

bizjournals.com Health Care:Pharmaceuticals headlines — Thu, 10 Nov 2011 17:37:24 +0100

Adolor Corp. on Thursday said that it registered a profit in the third quarter on the amortization of deferred revenue related to the end of a collaboration with GlaxoSmithKline on the Entereg drug. Exton, Pa.-based Adolor (NASDAQ:ADLR) said it earned $8.9 million, or 19 cents per share, in the quarter. In third-quarter 2010 the company lost $6.1 million. The company is set to be sold to Cubist Pharmaceuticals Inc. for at least $190 million. Adolor’s third-quarter 2011 revenue included $7.8 million in sales for Entereg and an increase of $15... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

ArQule Narrows 3Q Loss, Raises 2011 Forecast

Drugs.com - Pharma News — Thu, 10 Nov 2011 14:33:27 +0100

From Associated Press (November 10, 2011) WOBURN, Mass. -- ArQule Inc. said Thursday its third-quarter loss narrowed because revenue climbed after the biotechnology company received a milestone payment for the start of a drug trial in Asia. The... (Source: Drugs.com - Pharma News)

Medicis 3Q Profit Falls on Payments and Charges

Drugs.com - Pharma News — Thu, 10 Nov 2011 13:00:59 +0100

From Associated Press (November 9, 2011) SCOTTSDALE, Ariz. -- Shares of Medicis Pharmaceutical Corp. fell Wednesday after the company said its profit declined 29 percent in the third quarter on a series of one-time charges. Medicis said its profit... (Source: Drugs.com - Pharma News)

Drug Developer Medivation Takes Bigger 3Q Loss

Drugs.com - Pharma News — Thu, 10 Nov 2011 12:59:40 +0100

From Associated Press (November 10, 2011) SAN FRANCISCO -- Medivation Inc. on Wednesday reported a bigger third-quarter loss than it did a year earlier as it continued to develop treatments for prostate cancer and Alzheimer's disease. On Nov. 3,... (Source: Drugs.com - Pharma News)

Cleavage of rRNA ensures translational cessation in sperm at fertilization

Molecular Human Reproduction — Thu, 10 Nov 2011 05:00:00 +0100

Intact ribosomal RNAs (rRNAs) comprise the majority of somatic transcripts, yet appear conspicuously absent in spermatozoa, perhaps reflecting cytoplasmic expulsion during spermatogenesis. To discern their fate, total RNA retained in mature spermatozoa from three fertile donors was characterized by Next Generation Sequencing. In all samples, >75% of total sequence reads aligned to rRNAs. The distribution of reads along the length of these transcripts exhibited a high degree of non-uniformity that was reiterated between donors. The coverage of sequencing reads was inversely correlated with guanine-cytosine (GC)-richness such that sequences greater than ~70% GC were virtually absent in all sperm RNA samples. To confirm the loss of sequence, the relative abundance of specific regions of th...

MedWorm Sponsor Message: Find the best January Sales in the UK.

Affymax Takes Smaller 3Q Loss As Costs Decrease

Drugs.com - Pharma News — Wed, 09 Nov 2011 16:12:35 +0100

From Associated Press (November 9, 2011) PALO ALTO, Calif. -- Biotech drugmaker Affymax Inc. on Wednesday reported a smaller third-quarter loss and said it settled litigation with Johnson & Johnson over its top drug candidate, the anemia... (Source: Drugs.com - Pharma News)

Salix Pharma Posts 3Q Profit, Will Buy Oceana

Drugs.com - Pharma News — Wed, 09 Nov 2011 15:16:23 +0100

EDISON, N.J., November 8, 2011 (AP) ? Salix Pharmaceuticals Ltd. said Tuesday it turned a profit in the third quarter on rising sales of its drug Xifaxan, used to treat diarrhea and certain neurological problems. Salix also agreed to buy privately... (Source: Drugs.com - Pharma News)

A Root-Cause Analysis of Mortality Following Major Pancreatectomy

Journal of Gastrointestinal Surgery — Tue, 08 Nov 2011 06:47:48 +0100

Conclusion Root-cause analysis suggests that risk prediction should include, if not emphasize, operative factors related to pancreatectomy. While risk models can distinguish between mortalities and nonmortalities in a collective fashion, they vastly miscalculate the actual chance of death on an individual basis. This study reveals the contributions of both comorbidities and aggressive surgical decisions to mortality. Content Type Journal ArticleCategory 2011 SSAT Plenary PresentationPages 1-15DOI 10.1007/s11605-011-1753-xAuthors Charles Mahlon Vollmer, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USANorberto Sanchez, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston,...

Promoting corporate sustainability on the web

EurekAlert! - Social and Behavioral Science — Tue, 08 Nov 2011 05:00:00 +0100

(Inderscience Publishers) Almost three-quarters of Standard & Poor's top 500 US companies mentioned one or more sustainability programs on their websites. A new study shows that the largest companies are doing so in order to attract and maintain a profitable customer base rather than to actually incorporate and promote sustainability. Nevertheless, the side effect of their promotional efforts may be to boost such efforts within their company and have an impact on increasing adoption across various industries and services. (Source: EurekAlert! - Social and Behavioral Science)

Higher costs at SRI Surgical lead to 3Q red ink

bizjournals.com Health Care:Physician Practices headlines — Mon, 07 Nov 2011 22:27:07 +0100

SRI/Surgical Express Inc. reported a net loss of $534,000, or 8 cents a share, for the third quarter of 2011, compared with net income of $21,000, or 0 cents a share, for the third quarter of 2010. Although 3Q 2011 revenue was up 6.5 percent from the year-ago period, to $26.4 million, increased expenses for health insurance claims and commodity prices cut into the bottom line, a written company statement said. SRI (NASDAQ: STRC), a Tampa provider of central processing and supply chain management services to hospitals and surgery centers, said it continues to explore and evaluate strategic alternatives with no assurance that a transaction will result. (Source: bizjournals.com Health Care:Physician Practices headlines)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Stereotaxis loss grows to $7.3 million in Q3

bizjournals.com Health Care:Physician Practices headlines — Mon, 07 Nov 2011 21:53:01 +0100

Stereotaxis said today its loss widened in the third quarter to $7.3 million, compared with a loss of $5.1 million a year ago, on lower medical device sales. The St. Louis-based company, which makes cardiology instruments to treat coronary artery disease and arrhythmias, said revenue fell 38 percent to $8.5 million in the quarter ended Sept. 30, down from $13.9 million a year earlier. Last month, Stereotaxis’ senior management, including CEO Michael Kaminski, took voluntary pay cuts through 2013... (Source: bizjournals.com Health Care:Physician Practices headlines)

Kaiser swings to a big loss

bizjournals.com Health Care:Biotechnology headlines — Fri, 04 Nov 2011 22:07:35 +0100

Declines in financial markets played havoc with nonprofit Kaiser Permanente’s margin in the third quarter of 2011, causing a huge swing from solid profitability to a net loss of $45 million. The Oakland-based health plan and health system generated operating revenue of $11.9 billion for the quarter ended September 30, up from $11.1 billion for the same period last year. Operating income dropped to $320 million from $366 million over the same period — and net income plummeted to negative territory from a height of $634 million for the third quarter in 2010... (Source: bizjournals.com Health Care:Biotechnology headlines)

Kaiser Permanente’s Q3 takes hit from Wall Street woes

bizjournals.com Health Care:Biotechnology headlines — Fri, 04 Nov 2011 20:14:22 +0100

Kaiser Permanente’s nonprofit hospital and health plan units said Nov. 4 that their third-quarter profit took a gigantic hit due to non-operating losses, such as Wall Street investments. The Oakland-based health care giant had a net third-quarter loss of $45 million after posting a $634 million profit a year earlier – a nearly $680 million swing due primarily to a $365 million non-operating loss for the quarter. Its Kaiser Foundation Hospitals, Kaiser Foundation Health Plan Inc. and subsidiaries saw revenue jump 7... (Source: bizjournals.com Health Care:Biotechnology headlines)

Smith & Nephew in shift to low-cost countries

FT.com - Drugs and Healthcare — Fri, 04 Nov 2011 20:04:05 +0100

UK group to make more of its artificial hips and knees in low-cost countries such as China to reduce cost burden that hit third-quarter profits (Source: FT.com - Drugs and Healthcare)

Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)

BioHealth Investor — Fri, 04 Nov 2011 15:25:53 +0100

Vical Inc. (NASDAQ: VICL) and VIVUS, Inc. (NASDAQ: VVUS) are both running higher this Friday on news that Credit Suisse initiated both biotech outfits with “Outperform” ratings. What matters more than the call are the price targets and the inferences made in the research calls. Vical Inc. (NASDAQ: VICL) is rarely given huge analyst calls due to what is a small $250 million or so in market cap. The team at Credit Suisse initiated Vical with an “Outperform” rating this morning but more important is its price target of $7.00 per share. This represents more than a 100% move compared to the $3.45 close on Thursday. What was more impressive was the $7.00 price target versus a $3.45 close before, indicating just over 100% upside. Credit Suisse noted that Vical...

S&N profit falls on high orthopedics costs

Reuters: Health — Fri, 04 Nov 2011 09:55:03 +0100

LONDON (Reuters) - Smith & Nephew, Europe's largest artificial hip and knee maker, posted 9 percent lower third-quarter trading profit, saying its costs were too high for the subdued orthopedics market. (Source: Reuters: Health)

S&N Q3 profit falls as orthopedics margin disappoints

Reuters: Health — Fri, 04 Nov 2011 07:53:18 +0100

LONDON (Reuters) - Smith & Nephew, Europe's largest artificial hip and knee maker, missed third-quarter earnings expectations as its orthopedics business was squeezed by an adverse sales mix and high costs not appropriate in subdued market conditions. (Source: Reuters: Health)

Seattle Genetics beats Wall Street predictions for new cancer drug

bizjournals.com Health Care:Pharmaceuticals headlines — Fri, 04 Nov 2011 03:10:05 +0100

Seattle Genetics Inc. had a net loss of $40.7 million for the third quarter of 2011, but the company benefited from the recent launch of new cancer drug Adcetris. Third quarter revenues were $20.7 million this year, compared to $16.0 million in the third quarter of 2010. Seattle Genetics (NASDAQ: SGEN) revenues for the third quarter included $10 million in net sales of Adcetris to significantly beat Wall Street expectations of $1.9 million. Overall, Seattle Genetics' revenues were down for the first nine months of 2011, at $45... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Sanofi Says Net Profit Up 26 Percent

Drugs.com - Pharma News — Thu, 03 Nov 2011 15:16:40 +0100

Drug Maker Sanofi Says Net Profit Up 26 Percent PARIS (AP) — Drug maker Sanofi said Thursday that its net profit grew 26 percent in the third quarter, marking the start of a turnaround after several quarters of poor sales as the patents... (Source: Drugs.com - Pharma News)

Flu-Drug Revenue Falls for Biocryst

Drugs.com - Pharma News — Thu, 03 Nov 2011 14:42:00 +0100

[the News & Observer, Raleigh, N.C.] From News & Observer (Raleigh, NC) (November 3, 2011) Nov. 03--Drug company BioCryst Pharmaceuticals reported a wider third-quarter loss Wednesday because of reduced... (Source: Drugs.com - Pharma News)

Lexicon Pharma Posts Smaller 3Q Loss

Drugs.com - Pharma News — Wed, 02 Nov 2011 14:55:47 +0100

From Associated Press (November 1, 2011) THE WOODLANDS, Texas -- Lexicon Pharmaceuticals Inc. reported a smaller third-quarter loss Tuesday, and said it is negotiating with potential partners for its most advanced drug candidate. The drug developer... (Source: Drugs.com - Pharma News)

Teva Pharmaceutical 3Q Profit Slides 13 Percent

Drugs.com - Pharma News — Wed, 02 Nov 2011 12:57:15 +0100

From Associated Press (November 2, 2011) Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, said Wednesday its third-quarter profit fell 13 percent as North American sales dropped, partly because of a lack of... (Source: Drugs.com - Pharma News)

"Freshman 15" Just A Myth, Study

Health News from Medical News Today — Wed, 02 Nov 2011 11:00:00 +0100

A new study dispels the notion that college students gain 15 pounds (6.8 kilos) in their first year, what the authors describe as the "Freshman 15 media myth", and finds not only that the average weight gain is between 2.5 and 3.5 pounds (1.1 and 1.6 kilos), but moreover, that this has little to do with being at college, and much more to do with becoming a young adult. The study, due to be published in the December issue of Social Science Quarterly, appeared online last month... (Source: Health News from Medical News Today)

Pfizer profits surge on international demand

FT.com - Drugs and Healthcare — Tue, 01 Nov 2011 17:03:45 +0100

World's largest pharmaceutical company's third-quarter profits surge on greater demand in emerging markets and Capsugel business sale (Source: FT.com - Drugs and Healthcare)

Pfizer 3Q Profit Up on Higher Sales, Lower Charges

Drugs.com - Pharma News — Tue, 01 Nov 2011 15:58:38 +0100

Drug maker Pfizer Inc. beat Wall Street expectations with higher profit and revenue in the third quarter, the last before generic competition starts wiping out sales of Lipitor, the cholesterol blockbuster that has buoyed the company for... (Source: Drugs.com - Pharma News)

‘Living a life in shades of grey’: experiencing depressive symptoms in the acute phase after stroke

Journal of Advanced Nursing — Tue, 01 Nov 2011 04:00:00 +0100

Conclusion. The participants confirmed suffering from depressive symptoms, but depression was not seen as meaningful on its own. They related their experiences of post‐stroke depression in the acute phase to the losses they experienced. Nurses ought to take into account the depth of the life changes that stroke survivors may experience. There is a need for continued empirical research on how nurses may help and support stroke survivors dealing with depressive symptoms in the acute phase after stroke and how depressive symptoms develop over time. (Source: Journal of Advanced Nursing)

Beck Hopelessness Scale: Exploring its Dimensionality in Patients with Schizophrenia

Psychiatric Quarterly — Mon, 31 Oct 2011 17:02:15 +0100

This study aimed to examine the reliability and validity of the Taiwanese version of the Beck Hopelessness Scale (BHS-T) in a chronic schizophrenia out-patient sample. One hundred and two (102) outpatients were evaluated using the translated Taiwanese version of the BHS (BHS-T), as well as several Beck-related symptom rating scales and the Positive and Negative Syndrome Scale (PANSS) for psycho-pathology. The patients were also evaluated for suicidal intent using the critical items of the Scale for Suicide Ideation (SSI) and suicide attempts. The psychometric properties of the BHS-T were also evaluated, including construct validity, internal consistency, test–retest reliability, convergence, and discriminative validity. The BHS-T showed good overall reliability and stability over ...

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Who wants a slimmer body? The relationship between body weight status, education level and body shape dissatisfaction among young adults in Hong Kong

BMC Public Health - Latest articles — Mon, 31 Oct 2011 04:00:00 +0100

Conclusions: Overweight and obesity in men and underweight in women were prevalent among Hong Kong young adults. Inappropriate body shape desire might predispose individuals to unhealthy weight loss or gain behaviors. Careful consideration of actual weight status in body shape desire is needed in health promotion and education, especially for underweight and normal weight women and those with a low education level. (Source: BMC Public Health - Latest articles)

Earnings jump at HealthSouth in 3Q

bizjournals.com Health Care:Biotechnology headlines — Thu, 27 Oct 2011 21:32:00 +0100

HealthSouth Corp. (NYSE: HLS) recorded a significant boost in profits in the third quarter. The Birmingham-based owner and operator of inpatient rehabilitation hospitals reported net income of $68.3 million for the quarter. That’s up 63 percent from the same quarter last year, which saw a net profit of $41.9 million. HealthSouth CEO Jay Grinney called the showing a “another strong quarter” in a press statement that attributed the gains, in part, to 8 percent revenue growth during the quarter, from $460... (Source: bizjournals.com Health Care:Biotechnology headlines)

Cerner report will show whether growth pace is continuing

bizjournals.com Health Care:Biotechnology headlines — Thu, 27 Oct 2011 19:39:21 +0100

Cerner Corp. will reveal whether it’s been extending a recent growth curve when it announces third-quarter financial results Thursday afternoon. The North Kansas City-based company (Nasdaq: CERN) has recorded increases in revenue and profits in recent quarters as it benefits from the ongoing transition among hospitals and other health care providers from paper-based patient record systems to computer databases. That trend is being fueled further by federal health reform law requirements. UPDATE: Click here to see Cerner's third-quarter results Cerner designs electronic medical records software and systems, including offering to store the data and maintain the systems remotely... (Source: bizjournals.com Health Care:Biotechnology headlines)

Bristol-Myers Net Rises

WSJ.com: Health — Thu, 27 Oct 2011 13:21:17 +0100

Bristol-Myers Squibb reported a 2% rise in third-quarter profit, while increased sales of cancer drugs and the blood thinner Plavix contributed to revenue growth. (Source: WSJ.com: Health)

Earnings: CHS posts $96M 3Q profit

bizjournals.com Health Care:Pharmaceuticals headlines — Wed, 26 Oct 2011 21:22:28 +0100

Earnings at Community Health Systems Inc. (NYSE: CYH) were up 9 percent in the third quarter compared to the same period a year ago, the company said Wednesday. Earnings were $96 million, or 83 cents per share, on revenue of $3.4 billion. Analysts, on average, had anticipated earnings of 79 cents per share on revenue of $3.47 billion, according to Thomson Reuters. CHS officials said they were proud of the results in light of a challenging marketplace. “While our volumes have been constrained by the macroeconomic environment, we believe these results continue to demonstrate the underlying strength of our operating model,” said Wayne Smith, CHS’ chairman, president and CEO... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Sponsor Message: Find the best January Sales in the UK.

GlaxoSmithKline Q3 Net Profit Up 7 Percent

Drugs.com - Pharma News — Wed, 26 Oct 2011 16:06:34 +0100

LONDON (AP) - Growing sales in Japan and emerging markets have propelled drug maker GlaxoSmithKline to a 7 percent rise in profit in the third quarter, in line with market forecasts. The company reported Wednesday that net profit grew to... (Source: Drugs.com - Pharma News)

Germany's Merck Posts Higher Profit

WSJ.com: Health — Wed, 26 Oct 2011 08:30:52 +0100

Shares of German chemical and pharmaceutical company Merck KGaA rose over 5% as its third-quarter earnings beat expectations. (Source: WSJ.com: Health)

Human Genome Sciences reports 3Q losses

bizjournals.com Health Care:Physician Practices headlines — Tue, 25 Oct 2011 21:19:10 +0100

Rockville-based Human Genome Sciences Inc. saw losses widen and its revenue dip by a third in the third quarter this year compared with the same period a year ago. The biotech brought in $34 million in third-quarter revenue compared with $50.8 million in revenue last year. Most of this year's quarterly revenue was from product sales, including $18.8 million from its first commercial drug, lupus treatment Benlysta, and $12 million from government sales of its anthrax drug. In the second quarter of this year, Human Genome Sciences reported $7... (Source: bizjournals.com Health Care:Physician Practices headlines)

Novartis 3Q Profit Up 7 Pct; Plans 2,000 Jobs Cuts

Drugs.com - Pharma News — Tue, 25 Oct 2011 12:31:51 +0100

From Associated Press (October 25, 2011) GENEVA -- Swiss pharmaceutical giant Novartis AG posted a 7 percent increase in third-quarter net profit Tuesday as it announced 2,000 job cuts in an effort to save $200 million annually. Novartis said it... (Source: Drugs.com - Pharma News)

Novartis to cut 10% of Swiss workforce

FT.com - Drugs and Healthcare — Tue, 25 Oct 2011 11:31:41 +0100

Pharmaceuticals group sees buoyant third-quarter sales and profits (Source: FT.com - Drugs and Healthcare)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Analytical expression of confinement loss in Bragg fibers and its relationship with generalized quarter-wave stack condition

Journal of the Optical Society of America B — Mon, 24 Oct 2011 05:00:00 +0100

Analytical expression of confinement loss (CL) is presented for the TE mode of Bragg fibers by applying the perturbation theory to electromagnetic fields under an asymptotic expansion approximation. The expression can be used to evaluate CL for general cases as well as the quarter-wave stack (QWS) ... (Source: Journal of the Optical Society of America B)

Analytical expression of core and cladding material losses effect in Bragg fibers using the perturbation theory

Journal of the Optical Society of America B — Mon, 24 Oct 2011 05:00:00 +0100

We present an analytical expression of fiber loss caused by core and cladding material losses for the TE mode of hollow-core and nonhollow-core Bragg fibers using the perturbation theory. The fiber loss agrees well with previous numerical results. Under the quarter-wave stack (QWS) condition, the ... (Source: Journal of the Optical Society of America B)

Contagion film is not far from the truth, warns virus scientist

Guardian Unlimited Science — Sat, 22 Oct 2011 22:44:30 +0100

Dr Ian Lipkin, expert who advised on Soderbergh's movie, says we must be better prepared for outbreak of deadly diseaseIt's a classic Hollywood tale: scientists race against time to decode a killer virus that is spreading across the world. But the scientist who advised Oscar-winning director Steven Soderbergh on his new thriller, Contagion, says the events and themes of his latest film carry a very real warning for our times.Dr Ian Lipkin, professor of epidemiology, neurology and pathology at New York's Columbia University, was recruited as a senior technical adviser on Soderbergh's blockbuster. The film, which opened in cinemas on Friday, charts the emergence of a deadly infectious disease that ignites a pandemic.Scientists are first alerted after Beth Emhoff, played by Gwyneth Paltrow, b...

Marketing, Severance Costs Cut Lilly's 3rd-Quarter Profits 6 Percent

Drugs.com - Pharma News — Thu, 20 Oct 2011 15:56:59 +0100

Marketing, Severance Costs Cut Lilly's 3rd-Quarter Profits 6 Percent [the Indianapolis Star] From Indianapolis Star (IN) (October 20, 2011) Oct. 20--Eli Lilly and Co. said third-quarter profits slipped 6 percent, as it spent more marketing and... (Source: Drugs.com - Pharma News)

Eli Lilly Reports Decline in Q3 Net Profit

Drugs.com - Pharma News — Thu, 20 Oct 2011 15:25:17 +0100

From Benzinga Lightning Feed (October 20, 2011) Eli Lilly and Co (NYSE: LLY) reported a drop in its third-quarter net profit on Thursday. Eli Lilly's quarterly net profit declined to $1.24 billion, or $1.11 per share, from $1.30 billion, or $1.18... (Source: Drugs.com - Pharma News)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Baxter 3rd-Quarter Profit Rises 10 Percent

Drugs.com - Pharma News — Thu, 20 Oct 2011 15:14:40 +0100

From Associated Press (October 20, 2011) DEERFIELD, Ill. -- Baxter International Inc.'s third-quarter net income rose 10 percent, driven by strong demand for the drug maker's immune-system treatments and other therapies. Net income rose to $576... (Source: Drugs.com - Pharma News)

Three Things I’ve Learned

Red Cross Chat — Wed, 19 Oct 2011 13:32:42 +0100

Often I get asked to speak at events outside of the Red Cross. Last week I had the privilege of speaking at the Milton S. Eisenhower Symposium at Johns Hopkins University. Since I graduated from JHU in 1974 with the first class of female students, and my daughter is a student there now, I jumped at the opportunity. The symposium is an excellent student-run event that brings in an eclectic group of speakers, like Jerry Springer, Michael K. Williams from “The Wire,” and Obama advisor David Axelrod. The speakers are asked to “address the various strides America must take to strengthen its position in the global landscape and catapult the world towards the future.” When I read the speech topic, I thought, “What an unbelievably daunting topic.” So I decided to share with the student...

J&J Profit Falls 6.3% on Deal Costs

WSJ.com: Health — Tue, 18 Oct 2011 23:20:32 +0100

Johnson & Johnson posted higher quarterly sales but earnings fell 6.3% on write-downs related to its pending acquisition of Synthes. (Source: WSJ.com: Health)

J&J profits fall despite sales increases

FT.com - Drugs and Healthcare — Tue, 18 Oct 2011 17:36:18 +0100

Healthcare group reports decline in third-quarter profit as consumers shy away from expensive medical procedures and shift to cheaper medicines (Source: FT.com - Drugs and Healthcare)

Johnson & Johnson 3Q Profit Down 6 Percent

Drugs.com - Pharma News — Tue, 18 Oct 2011 14:31:23 +0100

From Associated Press (October 18, 2011) Johnson & Johnson's third-quarter profit fell 6 percent becuase larger overhead and production costs and a one-time charge offset higher foreign sales. The health care giant said... (Source: Drugs.com - Pharma News)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

JNJ Profit Drops, Revenue Jumps As New Drugs Are Rolled Out

Forbes.com Healthcare News — Tue, 18 Oct 2011 14:20:53 +0100

Worldwide health-care product maker Johnson & Johnson said its profit slipped 6.4% in the third quarter as it lost market share in its pharmaceutical segment to generic brands. (Source: Forbes.com Healthcare News)

Johnson & Johnson's Profit Falls 6.3%

WSJ.com: Health — Tue, 18 Oct 2011 13:35:20 +0100

Johnson & Johnson posted higher quarterly sales but earnings fell 6.3% on write-downs related to its pending acquisition of Synthes. (Source: WSJ.com: Health)

Obama administration 'bailed out' GM salmon firm

Guardian Unlimited Science — Tue, 18 Oct 2011 12:00:00 +0100

Low-loss unidirectional transducer for high frequency surface acoustic wave devices

Journal of Applied Physics — Sun, 16 Oct 2011 16:25:37 +0100

S. V. Biryukov, G. Martin, H. Schmidt, and B. Wall A multi-track unidirectional transducer for surface acoustic wave devices is presented. This transducer consists of periodic cells containing in each of the multiple tracks, only two electrodes and two gaps with quarter period width. So the structure has maximal possible dimensions of its elements f ... [J. Appl. Phys. 110, 076103 (2011)] published Fri Oct 14, 2011. (Source: Journal of Applied Physics)

Boca Raton hospital income dips in Q4

bizjournals.com Health Care:Physician Practices headlines — Fri, 14 Oct 2011 18:22:14 +0100

Boca Raton Regional Hospital saw its income dip in the fiscal fourth quarter, but it still finished the year with an overall financial improvement. The nonprofit earned $1.1 million on revenue of $92.9 million in the quarter ended June 30, down from earnings of $2.6 million on revenue of $86.9 million in the same quarter a year ago, according to a report to its bondholders. Higher expenses for labor, supplies, administrative costs and bad patient debt caused the decline in profitability. The higher labor costs came as the hospital added 51 employees over the past year, to reach 2,008... (Source: bizjournals.com Health Care:Physician Practices headlines)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Mycosporine-like amino acids from coral dinoflagellates.

Applied and Environmental Microbiology — Fri, 14 Oct 2011 04:00:00 +0100

Authors: Rosic NN, Dove S Abstract Coral reefs are one of the most important marine ecosystems, providing habitat for approximately a quarter of all marine organisms. Within the foundation of this ecosystem, reef-building corals form mutualistic symbioses with unicellular photosynthetic dinoflagellate of the genus Symbiodinium. Exposure to ultraviolet radiation (UVR: 280-400 nm) especially when combined with thermal stress, has been recognized as an important abiotic factor leading to the loss of algal symbionts from coral tissue and/or a reduction in their pigment concentration and coral bleaching. UVR may damage biological macromolecules, increase the mutagenesis level in the cells and destabilize the symbiosis between coral host and their dinoflagellate symbionts. In nature, cor...

What should be the top environmental priority for the next 40 years?

Guardian Unlimited Science — Wed, 12 Oct 2011 11:05:06 +0100

Experts speakers argue their cases ahead of an Earthwatch debate in London this weekEducation and population – Sir Crispin TickellOur society faces a rich complex of problems. Since the beginning of the industrial revolution some 250 years ago, our animal species has changed the character of the Earth's land surface, seas and atmosphere: hence the increasing use among geologists of the term Anthropocene to follow the Holocene epoch.Of all the interconnected problems we face, perhaps the most serious is the proliferation of our own species. Our numbers rose from around one million 12,000 years ago to around one billion 250 years ago. Since then there has been an extraordinary acceleration from 2 billion in 1930 to 6 billion at the end of the century and now approaching 7 billion.In seekin...

Longitudinal Assessment of Noise Exposure in a Cohort of Construction Workers

Annals of Occupational Hygiene — Wed, 12 Oct 2011 04:00:00 +0100

Conclusions: Construction workers in the cohort had subject-interval and study-average exposures which present a substantial potential risk of NIHL. In a subsequent paper, we will use these estimates to evaluate the exposure–response relationship between noise and NIHL. (Source: Annals of Occupational Hygiene)

Get Discounts On Medications With Co-Pay Assistance Cards

Tue, 11 Oct 2011 18:59:27 +0100

BOSTON (CBS) – When Haralee Weintraub was diagnosed with breast cancer, it was not only physically and emotionally devastating, it was also a financial hardship. “It ended up costing us $20,000 out of pocket from co-pays and drugs,” she said. There were times when Haralee even considered giving up medications because she couldn’t afford them. “It was scary to have to think that. This one pill that might ease my nausea is over $50. How nauseous am I?” she said. Now a growing number of local governments, doctors offices and non-profit agencies are offering co-pay cards to help people like Haralee. “Co-pay cards are sort of a relatively new phenomenon. We’ve really seen an increase in pharmaceutical companies putting these out,” explained Elizabeth Messenger of Needymeds...

The fight against HIV/Aids – get on board with Unitaid | Jill Filipovic

Guardian Unlimited Science — Tue, 04 Oct 2011 16:00:02 +0100

A group tackling HIV/Aids in developing countries is using innovative methods that even drugs companies could likeDaniel is six months old, and one of the more than a million children in Africa born of HIV-positive mothers every year. Without prenatal treatment, up to 30% of these children will contract the virus. Daniel is one of the luckier ones, so far. His mother, Elise, found out she was HIV-positive eight months ago, while she was pregnant with him. She took the necessary antiretrovirals to decrease the risk of transmission. But Elise lives in rural Cameroon, and since she was diagnosed has travelled two hours by car every month to the closest clinic to get the drugs necessary to prevent transmission to her child. The travel is expensive, but she wants her son to be negative, and she...

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

More 2011 Hospital Layoffs Announced

About.com Health Careers — Mon, 03 Oct 2011 22:09:44 +0100

With several hospital layoffs planned for the fourth quarter of 2011, many healthcare industry analysts are predicting doom and gloom for the hospital industry, although the healthcare industry has remained strong and performed well throughout the recession and recovery. Not-for-profit hospitals are particularly at risk, according to a report by The Advisory Board Company...Read Full Post (Source: About.com Health Careers)

Self‐management strategies in overweight/obese Canadians with arthritis (brief report)

Arthritis Care and Research — Mon, 03 Oct 2011 04:00:00 +0100

Conclusion:Fewer than half overweight/obese Canadians with arthritis engaged in both weight control/loss and exercise. The provision of targeted clinical recommendations (particularly low in individuals that did not engage in any self‐management strategies) may help to facilitate participation. © 2011 by the American College of Rheumatology. (Source: Arthritis Care and Research)

---

Annales de Chirurgie Plastique et Esthetique — Mon, 19 Sep 2011 04:00:00 +0100

CONCLUSION: Reconstruction of one or both ears is often the last step in a rehabilitation process after burns. It is ideally performed after wound healing has been achieved, and by a team well trained in microtia treatment and post-traumatic reconstruction. PMID: 21937159 [PubMed - as supplied by publisher] (Source: Annales de Chirurgie Plastique et Esthetique)

[Reconstruction of the burned ear.]

Annales de Chirurgie Plastique et Esthetique — Mon, 19 Sep 2011 04:00:00 +0100

Investigating the mechanism for maintaining eucalcemia despite immobility and anuria in the hibernating American black bear (Ursus americanus)

Bone — Mon, 19 Sep 2011 04:00:00 +0100

This study presents a radiographic and biochemical picture of bone metabolism in free-ranging, female American black bears (Ursus americanus) that were active (spring bears and autumn bears) or hibernating (hibernating bears). Hibernating bears included lactating and non-lactating individuals. We measured serum calcium, albumin, inorganic phosphate, creatinine, bone specific alkaline phosphatase (BSALP), CTX, parathyroid hormone, insulin-like growth factor-I (IGF-l), leptin, 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)2D] and sclerostin from 35 to 50 tranquilized hibernating bears and 14 to 35 tranquilized spring bears. We compared metacarpal cortical indices (MCI), measured by digital X-ray radiogrammetry, from 60 hunter-killed autumn bears and 79 tranquilized, hiberna...

MedWorm Sponsor Message: Find the best January Sales in the UK.

Bupropion Versus Sertraline in the Treatment of Depressive Patients with Binge Eating Disorder: Retrospective Cohort Study

Psychiatric Quarterly — Sat, 17 Sep 2011 05:48:48 +0100

This study sought to compare Bupropion versus Sertraline in the treatment of depressed patients with Binge Eating Disorder (BED) prescribed off-label. Medical records of outpatients with diagnosis of BED and Depression (DSM-IV-TR criteria) were selected: 15 patients were treated with bupropion 150 mg/per day, and 15 with sertraline 200 mg/per day. During the screening and control visits (2°–6°–14°–24° week), the selected patients were first weighed and then evaluated using the following questionnaires: Binge Eating Disorder-Clinical Interview (BEDCI), Beck Depression Inventory (BDI), State-Trait Anxiety Inventory X (STAI-X) and Arizona Sexual Experience Scale (ASEX). Both drugs reduced anxious-depressive symptoms and binge frequency: Bupropion showed a better...

Pharmacological Treatment of Bipolar Depression: Qualitative Systematic Review of Double-Blind Randomized Clinical Trials

Psychiatric Quarterly — Sat, 17 Sep 2011 05:48:46 +0100

The objective of this study is to carry out a qualitative analysis of RCT methodology in the treatment of bipolar depression (BD). A systematic review covering the last 20 years was performed on PubMed selecting double-blind RCTs for BD. The identification items of the articles, their design, methodology, outcome and grant-related issues were all analyzed. Thirty articles were included, all of which had been published in journals with an impact factor >3. While almost half studies (46.7%) used less than 50 patients as a sample, 70% did not describe or did not perform sample size calculation. The Last Observation Carried Forward (LOCF) method was used in 2/3 of the articles and 53.4% of the studies had high sample losses (>20%). Almost half the items were sponsored by the p...

Reasons Why Patients Remain Uninsured after Massachusetts’ Health Care Reform: A Survey of Patients at a Safety-Net Hospital

Journal of General Internal Medicine — Fri, 16 Sep 2011 05:51:06 +0100

CONCLUSIONS After full implementation of the Massachusetts health reform, those remaining without insurance are largely the working poor who do not have access to, or cannot afford, either employer sponsored insurance or state subsidized insurance. Content Type Journal ArticleCategory Original ResearchPages 1-7DOI 10.1007/s11606-011-1868-5Authors Rachel Nardin, Department of Medicine, Cambridge Health Alliance, 1493 Cambridge St; Macht 420, Cambridge, MA 02139, USAAssaad Sayah, Department of Emergency Medicine, Cambridge Health Alliance, Cambridge, MA, USAHermione Lokko, Harvard Medical School, Boston, MA, USASteffie Woolhandler, City University of New York School of Public Health, New York, NY, USADanny McCormick, Department of Medicine, Cambridge Health Alliance, 1...

Supporting Your 20-Something Child into Healthy Adulthood

Psych Central — Thu, 15 Sep 2011 13:25:39 +0100

Are we doing enough to support our 20-somethings’ transition into a healthy adulthood? In some ways, today’s young adults have more support than in years past. Twenty-somethings are now an identified group in our culture. There is a higher level of understanding and normalization of the difficulties young people can face in a ‘quarter-life crisis.’ Young adults also now have access to an increasing amount of information about how to use their 20s as a time to make conscious schooling and career choices. What I have found to be missing, however, is help for 20-somethings to safely and effectively address the deeper psychological issues that often come up for them at this age. While each person is unique, and some young adults, for various reasons, do not have these issues aris...

Pharmacyclics Reports Greater 4Q Research Costs

Drugs.com - Pharma News — Tue, 13 Sep 2011 14:35:37 +0100

From Associated Press (September 12, 2011) SUNNYVALE, Calif. -- Drug developer Pharmacyclics Inc. reported a larger fiscal fourth-quarter loss as it spent on studies for a drug intended to treat leukemia and lymphoma. The company said it lost... (Source: Drugs.com - Pharma News)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Polydex Reports Growing Sales and Cost Management Initiatives Result in Profitable 2nd Quarter

Medical News (via PRIMEZONE) — Mon, 12 Sep 2011 13:15:00 +0100

TORONTO, Sept. 12, 2011 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the "Company") reports financial results for the second quarter of fiscal 2012, the three-month period ending July 31, 2011. All figures are reported in U.S. dollars. (Source: Medical News (via PRIMEZONE))

Memorial Healthcare System shows better profits

bizjournals.com Health Care:Biotechnology headlines — Fri, 09 Sep 2011 20:40:14 +0100

Memorial Healthcare System showed strong profits in the first quarter of its fiscal year. The Hollywood-based public health system earned $24.1 million on revenue of $359.7 million in the quarter ended July 31. That’s up from earnings of $22.2 million on revenue of $338 million in the same period a year ago. Its income from operations improved to $9.9 million from $1.7 million. That helped offset lower property tax revenue. Hospital admissions decreased during the quarter, but bed occupancy rate increased because patients tended to stay longer... (Source: bizjournals.com Health Care:Biotechnology headlines)

Survey Finds High Alzheimer’s Awareness

Psych Central — Wed, 07 Sep 2011 13:44:35 +0100

A large survey has found that most people would rapidly seek medical advice if they developed symptoms of Alzheimer’s disease. The survey covered 2,678 adults in the U.S., Germany, France, Spain and Poland. It focused on the public perception and awareness of Alzheimer’s disease, and was carried out by Harvard School of Public Health, Boston, Mass., and the nongovernmental organization Alzheimer Europe. Findings were presented on July 20 at the Alzheimer’s Association International Conference 2011, held in Paris, France. More than 85 percent of respondents would want to see a physician if they were experiencing confusion or memory loss, to find out if the symptoms were due to Alzheimer’s disease. A very high rate (over 94 percent) said they would want the same for ...

Disability, absence and the health reform era.

Benefits Quarterly — Mon, 05 Sep 2011 11:20:02 +0100

This article reviews several challenges employers face in managing employee health and absence in a well-integrated manner. Although such an undertaking is not easy, the additional cost national health care reform may bring makes the interrelationship between employer profitability and employee absence, health and disability more crucial than ever for employers to recognize and manage. PMID: 21879608 [PubMed - in process] (Source: Benefits Quarterly)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Digest

Progress in Neurology and Psychiatry — Thu, 01 Sep 2011 04:00:00 +0100

AbstractNewsNICE guideline on ADHDConsultation on the NICE guideline on ADHD (CG72) has now ended. The scheduled review will consider new evidence on diagnosis, management and the organisation of care emerging since the guideline was published in 2008. New clinical trials confirm current recommendations for the treatment of children, NICE says, and support the use of methylphenidate as firstline therapy in adults followed by atomoxetine or dexamfetamine for patients who do not respond to or who are intolerant of six weeks' treatment with methylphenidate.NICE stroke recommendationsAbout half of patients with suspected stroke are initially managed in line with NICE's recommendations, according to an audit by the Royal College of Physicians (www.rcplondon.ac.uk). The College's Stroke Improvem...

Generating thermotolerant colonies by pairing Beauveria bassiana isolates

FEMS Microbiology Letters — Wed, 31 Aug 2011 04:47:36 +0100

AbstractLow thermotolerance in entomopathogenic fungi is the main impediment to their industrialization. This research, for the first time, describes the generation of a thermotolerant colony by pairing and subculturing (cycling) two Beauveria bassiana isolates without sexual reproduction. A mixture of B. bassianaERL1578 and ERL1576 was inoculated on quarter‐strength Sabouraud dextrose agar with yeast extract (¼SDAY). The paired culture (ERL1578+1576) was cycled three times to increase the low frequency of possible hyphal fusion at the 1st cycle (~5/5×105 conidia), followed by a heat treatment as a selection pressure. Non‐paired two isolates served as controls. Two morphologically different colonies (BbHet1 and BbHet2) were isolated from the pairing. BbHet1 colony had the highest con...

A national review of cesarean delivery in Ethiopia

International Journal of Gynaecology and Obstetrics — Mon, 29 Aug 2011 04:00:00 +0100

Conclusion: The study showed little progress in the proportion of all births delivered by cesarean and a high rate of cesarean among women attended in the private sector—indicating a need to monitor the appropriateness of obstetric care in all sectors and to increase access in rural areas. Clinical management protocols for obstetric and newborn care are needed, and audits of cesareans should be performed at all institutions, especially in the private sector. The importance of improving record keeping is crucial for informed local decision-making. (Source: International Journal of Gynaecology and Obstetrics)

Loss Of Health Insurance Through Unemployment Means Many Skip Needed Health Care

Health News from Medical News Today — Fri, 26 Aug 2011 07:00:00 +0100

Nearly three-quarters (72%) of people who lost their health insurance when they lost their jobs over the last two years said that they skipped needed health care or did not fill prescriptions because of cost, according to a new Commonwealth Fund report. The same proportion is also struggling with medical bills or medical debt, compared to about half (49%) who lost jobs but not their health insurance... (Source: Health News from Medical News Today)

Medtronic Profit Falls on Weaker Margins

WSJ.com: Health — Tue, 23 Aug 2011 17:05:15 +0100

Medtronic's fiscal first-quarter earnings fell 1.1% as the medical-device maker's margins weakened, though sales improved despite challenges in the markets for heart rhythm and spinal devices. (Source: WSJ.com: Health)

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

The effect of clockwise and counterclockwise twisting moments on abutment screw loosening

Clinical Oral Implants Research — Wed, 17 Aug 2011 23:00:00 +0100

ConclusionsWithin the limitations of this study, there was little effect of twisting moment direction on the total torque loss of an internal hexagon connection implant system. This could be attributed to the anti‐twisting mechanism of the internal hexagon connection. (Source: Clinical Oral Implants Research)

Offspring searching for their sperm donors: how family type shapes the process

Human Reproduction — Tue, 16 Aug 2011 23:00:00 +0100

CONCLUSIONS Although the findings are not based on a random sample, the desire among offspring surveyed here is for greater openness and contact with their donor. A variety of strategies are needed for offspring of heterosexual couples to benefit optimally from the general trend toward openness in gamete donation. (Source: Human Reproduction)

MedQuist reports $5.5M profit

bizjournals.com Health Care:Pharmaceuticals headlines — Tue, 16 Aug 2011 19:36:32 +0100

MedQuist Holdings Inc. reported earnings of $5.5 million available to common shareholders in the second quarter, a turnaround from a loss of $2.2 million in the same time period last year. The earnings for the quarter ended June 30 came on $108.4 million in revenue, a slight decrease from last year. Analysts estimated on average a earnings per share of 30 cents, and MedQuist (PINK:MEDQ) came in beneath that at 11 cents. In a statement, chairman and CEO Vern Davenport touted improvements in operations and expectations of an acquisition of M*Modal to wrap up this month... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Catalyst Pharmaceutical Partners Announces Second Quarter 2011 Financial Results

Medical News (via PRIMEZONE) — Tue, 16 Aug 2011 12:03:00 +0100

CORAL GABLES, Fla., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced its financial results for the second quarter and six months ended June 30, 2011. For the three months ended June 30, 2011, the Company reported a net loss of $1,394,151, or $0.06 per basic and diluted share, compared to a net loss of $1,328,541, or $0.07 per basic and diluted share, for the same period in 2010. For the six months ended June 30, 2011, the Company reported a net loss of $2,911,287, or $0.14 per basic and diluted share, compared to a net loss of $2,373,584, or $0.13 per basic and diluted share, for the same period in 2010. (Source: Medical News (via PRIMEZONE))

EntreMed posts $1.7M loss

bizjournals.com Health Care:Pharmaceuticals headlines — Mon, 15 Aug 2011 14:54:36 +0100

Rockville-based EntreMed Inc., which is developing a treatment for ovarian cancer, posted a smaller loss for its latest quarter as it spent less on research and development. The company said it expects to report results from clinical trials in its ovarian cancer study in the third quarter. EntreMed had a second-quarter net loss of $1.7 million, or 17 cents per share, compared with a net loss of $4.9 million, or 57 cents per share, a year earlier. It ended the quarter with $3.8 million in cash and cash equivalents... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

MedWorm Sponsor Message: Find the best January Sales in the UK.

GeoVax records $211,000 Q2 loss

bizjournals.com Health Care:Pharmaceuticals headlines — Fri, 12 Aug 2011 20:44:28 +0100

GeoVax Labs Inc. (OTC BB: GOVX) The Atlanta-based HIV/AIDS vaccine developer posted a smaller loss in the second quarter, aided by higher grant revenue. Grant Revenue: $1.75 million, up 1.2 percentNet Loss: ($211,000), N/MLoss Per Share: (1 cent), N/M Dr. Robert T. McNally, president and CEO: "While the continued progress of our clinical development programs remains our priority, financing efforts have represented a major activity during the last quarter. Our current cash balances, together with anticipated proceeds from our NIH grant, are sufficient to support our planned operations into 2012... (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Fortis Healthcare Swings to Profit

WSJ.com: Health — Fri, 12 Aug 2011 10:47:12 +0100

India's Fortis Healthcare said it swung to a first-quarter net profit, helped by higher sales and a sharp drop in interest payments. (Source: WSJ.com: Health)

Ironwood's loss widened ahead of FDA drug submission

bizjournals.com Health Care:Hospitals headlines — Thu, 11 Aug 2011 19:32:48 +0100

Ironwood Pharmaceuticals (Nasdaq: IRWD) announced its net loss widened in the second quarter, as the company’s costs grew in the final stretch of development for its potential therapy for irritable bowel syndrome. The results were in line with analyst expectations, and investors buoyed the stock by more than 8 percent, Thursday, as the Nasdaq Composite index rose 4.6 percent in afternoon trading. The Cambridge, Mass.-based biotechnology company reported a net loss of $18.8 million in the three months ending June 30, versus a loss of $17... (Source: bizjournals.com Health Care:Hospitals headlines)

Badgers culls don't stop tuberculosis in cattle – the evidence is clear | Julia Kaminski

Guardian Unlimited Science — Thu, 11 Aug 2011 08:00:00 +0100

The government is ignoring scientists' advice on bovine TB – killing badgers is not the solutionMembers of the public who may know little about farming – or wildlife – could be forgiven for thinking that farmers' lives are being ruined by badgers.It is a message being peddled by the farming press, by some – but not all – farmers, and even by the BBC's Countryfile programme. They say that thousands of cattle are being slaughtered every year (30,000 in 2010) because of bovine tuberculosis (bTB) – an airborne respiratory disease – at enormous cost to farmers and the taxpayer: £100m last year. This much is true. They also say that bTB is being passed to cattle by badgers. This I dispute, based on evidence from those who know better than me – scientists.Those of us who want to ...

MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to 15 years in Bahrain. #FreeDoctors

Rotech reports revenue drop, loss

bizjournals.com Health Care:Physician Practices headlines — Wed, 10 Aug 2011 13:21:43 +0100

Rotech Healthcare Inc. reported a drop in net revenue for the second quarter and the first half of the year, and a loss for both periods. Orlando-based Rotech (OTCBB: ROHI) reported second-quarter net revenue of $122.4 million, down from $124.3 million during the same period a year ago. Net revenue for the first six months of the year was $243.9 million, down from $247.7 million during the same period a year ago. The home medical equipment company reported a loss of $2 million for the quarter, compared to a profit of $3... (Source: bizjournals.com Health Care:Physician Practices headlines)

Chinese Pharma Firm's 2Q Profit Climbs 91 Percent

Drugs.com - Pharma News — Tue, 09 Aug 2011 15:58:24 +0100

Simcere Pharma 2Q Profit Climbs 91 Percent From Associated Press (August 9, 2011) Simcere Pharmaceutical Group said Tuesday its second-quarter net income rose 91 percent, helped in part by sales growth for the cancer drugs Endu and Sinofuan and a... (Source: Drugs.com - Pharma News)

Kaiser Permanente's Q2 profits soar 64%

bizjournals.com Health Care:Biotechnology headlines — Sun, 07 Aug 2011 05:00:30 +0100

Kaiser Permanente's nonprofit hospital and health plan units said Friday their second quarter net income soared 64 percent, from $404 million a year ago to $663 million for the quarter ending June 30. Its Kaiser Foundation hospitals, Kaiser Foundation Health Plan Inc., and subsidiaries also saw operating revenue jump 8 percent from $11 billion in 2010's second quarter to $11.9 billion this time; while operating income increased nearly 25 percent from $313 million to $390 million and net non-operating income, reflecting investments, tripled from $91 million a year ago to $273 million... (Source: bizjournals.com Health Care:Biotechnology headlines)